Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea

NCT ID: NCT02541188

Last Updated: 2021-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

460 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-02

Study Completion Date

2017-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breast cancer are common on mediterranean basin. Epidemiological data suggest that breast cancer in young women (\< 40years old) is more aggressive in the Maghreb countries comparatively to western countries. This aggressiveness could be associated with phenotypic and genotypic differences between this two populations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The object of this study is to compare the genotypic and phenotypic differences between south and north shore of the mediterranean sea.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Breast cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

breast cancer in young women is in the Maghreb

breast cancer in young women (\< 40years old) is in the Maghreb

Genetic analysis

Intervention Type GENETIC

Breast cancer in young women in the western countries

Breast cancer in young women (\< 40years old) in the western countries

Genetic analysis

Intervention Type GENETIC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Genetic analysis

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient have or have had a breast cancer diagnosed before 40 years old
* Breast cancer proven by histology
* BRCA1/2 analysis proposed, realized, ongoing
* Women \>18 years old
* Patient with insurance
* Patient informed and no-opposed

Exclusion Criteria

* Patient have or have had a breast cancer diagnosed after 40 years old
* Patient requiring tutorship or guardianship
* Adult patient protected by law
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pascal PUJOL, MDPhD

Role: PRINCIPAL_INVESTIGATOR

Oncogenetic Unit -CHU de Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Montpellier

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UF 9428

Identifier Type: -

Identifier Source: org_study_id